+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Sennidin A

BP1290
641-12-3
98%
普瑞法
Sennidin A, has two hydroxyanthraquinone-like moieties, exerts inhibition on NS3 helicase with IC50 values of 0.8 uM. Sennidin A in combination with necrosis inducing drugs/therapies may generate synergetic tumoricidal effects on solid malignancies by means of primary debulking and secondary cleansing process. It stimulates glucose incorporation in the phosphatidylinositol 3-kinase (PI3K)- and Akt-dependent in rat adipocytes, but in the IR/IRS1-independent manner.
Catalog No Package Original Price Price Inventory Quantity Operating
BP1290-5mg 5mg
BP1290-10mg 10mg
BP1290-20mg 20mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

PTPN1 AMPK PPARG PIK3CA AKT1 IRS1 SLC2A4
PTPN1 PPARG PIK3CA AKT1 IRS1 SLC2A4
PTPN1 AMPK PPARG AKT1 IRS1 SLC2A4
CFTR SLC9A3 AQP3 AQP4 AQP8

Sennidin A Related Products

Product drug property prediction parameters

  • 189.6600

  • 3.6773

  • .5656

  • .0370

  • 3.9375

  • 1.8957

  • Low

  • 92.4107

  • 3.6474

  • Yes

  • No

  • No

  • No

  • Yes

  • Yes

  • 0.0

  • Yes

  • No

  • Yes

  • No